Li Mao

23.0k citations
363 papers · 17.6k · 3 hit papers · h-index 66

Impact in

Papers in

    • Epigenetics and DNA Methylation 34
    • RNA modifications and cancer 34
    • Cancer-related gene regulation 21
    • Cancer-related Molecular Pathways 25
    • Pancreatic and Hepatic Oncology Research 13

Li Mao

350 papers receiving 17.1k citations

Li Mao's Hit Papers

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers 1995 · 1.7k citations
1.7k0+10+20Years since publication50010001.5k

Peers

Li Mao
Comparison fields: 5 of 189
  • Otorhinolaryngology 1.3k
  • Cancer Research 3.0k
  • Periodontics 832
  • Oncology 4.8k
  • Molecular Biology 9.0k
Replace Wan L. Lam with:
Wan L. Lam Canada
Jennifer R. Grandis United States
Qingyi Wei United States
Fei‐Fei Liu Canada
Vassilis G. Gorgoulis Greece
Andres J. Klein–Szanto United States
Alfred K. Lam Australia
Philip J. Coates United Kingdom
Marco A. Pierotti Italy
David L. Lacey United States
Li Mao relative to Wan L. Lam Canada Wan L. Lam's profile →
Citations per field
00.5×1.5×2.4×
Wan L. Lam · 1×
Citations per year

Countries citing papers authored by Li Mao

Since Specialization
Citations

This map shows the geographic impact of Li Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Mao more than expected).

Fields of papers citing papers by Li Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Mao. The network helps show where Li Mao may publish in the future.

Co-authors

The 25 scholars most cited alongside Li Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Li Mao Line = papers co-authored together Li Mao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 363 papers — load more, or switch the sort, to bring in the rest.

#Work
1
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
Hit paper breakdown →
19951723
2
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
Hit paper breakdown →
19951194
3
Molecular Assessment of Histopathological Staging in Squamous-Cell Carcinoma of the Head and Neck
Hit paper breakdown →
1995616
4 1996433
5
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
2002356
6
Predicting cancer development in oral leukoplakia: ten years of translational research.
2000326
7 2007325
8 2004317
9 2008289
10
Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.
2000262
11 2006258
12 2007247
13 2009234
14 2004220
15 2019184
16 2020178
17 2003174
18 2008172
19 2012171
20
Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc.
1998157

About Li Mao

Li Mao is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 363 papers that have together received 17.6k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (34 papers), RNA modifications and cancer (34 papers), Cancer-related Molecular Pathways (25 papers), Cancer-related gene regulation (21 papers), Head and Neck Cancer Studies (16 papers), MicroRNA in disease regulation (15 papers), Pancreatic and Hepatic Oncology Research (13 papers) and Lung Cancer Treatments and Mutations (11 papers). The work is most often cited by research in Otorhinolaryngology (1.3k citations), Cancer Research (3.0k citations), Periodontics (832 citations), Oncology (4.8k citations) and Molecular Biology (9.0k citations). Li Mao has collaborated with scholars based in China, United States and France. Frequent co-authors include Waun Ki Hong, David Sidransky, Adrian Merlo, James G. Herman, Stephen B. Baylin, Jean‐Pierre J. Issa, Daniel J. Lee, Edward Gabrielson, Peter C. Burger and Adel K. El‐Naggar. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Oncogene, PLoS ONE and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact